Abbott (ABT) Tops Q3 EPS by 47c, Sales Beat
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $103.36 -1.78%
Revenue Growth %: +14.2%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.2%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q3 EPS of $1.40, $0.47 better than the analyst estimate of $0.93. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $9.44 billion.
GUIDANCE:
Abbott sees FY2021 EPS of $5.00-$5.10, versus the consensus of $4.45.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
- Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
